Hyundai IBT develops and commercializes Drug Delivery System platform technologies for safe and efficient delivery of
drugs or active ingredients to the human body, built by our proprietary Organic-Inorganic Hybrid technologies.
This technology was introduced as a promising innovative technology by the Materials Research Society and Chemical &
Engineering; also recognized by Nature and Angewandte Chemie. We have numerous patent registrations and applications
across the world.
Our technologies allow the selective and effective delivery of active substances on a targeted area of the human body
through bio-friendly mineral layered carriers. From cosmeceutical achievements such as Vitabrid C12, to tumor-targeted
drug/RNA delivery technologies, our research and commercialization continues.